Table 2

Causes of death reported in COMFORT-2 in both the ruxolitinib and BAT treatment arms after a median total follow-up of 61.1 weeks

Ruxolitinib armBest available therapy
CauseNumber of casesCauseNumber of cases
Myelofibrosis Pneumonia, septic shock, multisystem organ failure, and acute myeloid leukemia 
Hepatic failure, cerebral hemorrhage, and portal vein thrombosis after surgery for metastatic squamous cell carcinoma of the head and neck Postsplenectomy Klebsiella pneumoniae sepsis 
Pulmonary edema and cardiac arrhythmia Splenectomy, peritoneal hemorrhage, and respiratory failure 
Retroperitoneal hemorrhage after an orthopedic procedure Renal failure and acute myeloid leukemia 
Intestinal perforation associated with terminal ileitis   
Respiratory infection   
Cardiac arrest and myelofibrosis   
Cardiac failure   
Pulmonary extramedullary hematopoiesis and pulmonary failure   
Posttransplantation lymphoproliferative disorder and multiorgan failure   
Total 11 Total 4 
Ruxolitinib armBest available therapy
CauseNumber of casesCauseNumber of cases
Myelofibrosis Pneumonia, septic shock, multisystem organ failure, and acute myeloid leukemia 
Hepatic failure, cerebral hemorrhage, and portal vein thrombosis after surgery for metastatic squamous cell carcinoma of the head and neck Postsplenectomy Klebsiella pneumoniae sepsis 
Pulmonary edema and cardiac arrhythmia Splenectomy, peritoneal hemorrhage, and respiratory failure 
Retroperitoneal hemorrhage after an orthopedic procedure Renal failure and acute myeloid leukemia 
Intestinal perforation associated with terminal ileitis   
Respiratory infection   
Cardiac arrest and myelofibrosis   
Cardiac failure   
Pulmonary extramedullary hematopoiesis and pulmonary failure   
Posttransplantation lymphoproliferative disorder and multiorgan failure   
Total 11 Total 4 
Close Modal

or Create an Account

Close Modal
Close Modal